X
No Ads. No Trackers. No Kidding! (Learn More)
Loading...
VP,... [Read More]
Thumbnail
Jounce Therapeutics' market cap has dropped by around 7x from its peak of over $900M 2 years ago. Its lead program has 2 development plans... [Read More]
The FDA has granted Fast Track designation to IVERIC bio's (NASDAQ:ISEE) Zimura (avacincaptad pegol), a novel complement C5 inhibitor, in development for the treatment of geographic atrophy... [Read More]
BrainStorm Cell Therapeutics (NASDAQ:BCLI) has been awarded a new grant of ~$1.5M by the Israel Innovation Authority (IIA).The grant will enable continued development of advanced... [Read More]
Save As
Preview
Preview